A QTL on 12q Influencing an inflammation marker and obesity in white women: The NHLBI family heart study

Obesity

Volumn 17, Issue 3, 2009, Pages 525-531

  Wu, Jun ^a   Pankow, James S ^b   Tracy, Russell P ^c   North, Kari E ^d   Myers, Richard H ^e   Feitosa, Mary E ^a   Province, Michael A ^a   Borecki, Ingrid B ^a  

^a WASHINGTON UNIVERSITY   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c UNIVERSITY OF VERMONT   (United States)

^d UNIVERSITY OF NORTH CAROLINA   (United States)

^e BOSTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN;

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; BLOOD; BODY MASS; CAUCASIAN; CHROMOSOME 12; ETHNOLOGY; FEMALE; GENETIC LINKAGE; GENETICS; HUMAN; MALE; METABOLISM; MIDDLE AGED; OBESITY; QUANTITATIVE TRAIT LOCUS; SEX DIFFERENCE;

ADULT; AFRICAN AMERICANS; AGED; BODY MASS INDEX; C-REACTIVE PROTEIN; CHROMOSOMES, HUMAN, PAIR 12; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; LINKAGE (GENETICS); MALE; MIDDLE AGED; OBESITY; QUANTITATIVE TRAIT LOCI; SEX FACTORS;

EID: 60849135739     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2008.556     Document Type: Article

References (44)

1. Poirier P, Giles TD, Bray GA et al. Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss. Circulation 2006;113:898-918.
2. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005;352:1685-1695.
3. Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 1993;259:87-91.
4. Kern PA, Saghizadeh M, Ong JM et al. The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase. J Clin Invest 1995;95:2111-2119.
5. Loskutoff DJ, Samad F. The adipocyte and hemostatic balance in obesity: studies of PAI-1. Arterioscler Thromb Vasc Biol 1998;18:1-6.
6. Yudkin JS, Stehouwer CD, Emeis JJ, Coppack SW. C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol 1999;19:972-978.
7. Visser M, Bouter LM, McQuillan GM, Wener MH, Harris TB. Elevated C-reactive protein levels in overweight and obese adults. JAMA 1999;282:2131-2135.
8. Borecki IB, Higgins M, Schreiner PJ et al. Evidence for multiple determinants of the body mass index: the National Heart, Lung, and Blood Institute Family Heart Study. Obes Res 1998;6:107-114.
9. Rice T, Perusse L, Bouchard C, Rao DC. Familial aggregation of body mass index and subcutaneous fat measures in the longitudinal Quebec family study. Genet Epidemiol 1999;16:316-334.
10. Luke A, Guo X, Adeyemo AA et al. Heritability of obesity-related traits among Nigerians, Jamaicans and US black people. Int J Obes Relat Metab Disord 2001;25:1034-1041.
11. Pankow JS, Folsom AR, Cushman M et al. Familial and genetic determinants of systemic markers of inflammation: the NHLBI family heart study. Atherosclerosis 2001;154:681-689.
12. Vickers MA, Green FR, Terry C et al. Genotype at a promoter polymorphism of the interleukin-6 gene is associated with baseline levels of plasma C-reactive protein. Cardiovasc Res 2002;53:1029-1034.
13. Best LG, North KE, Tracy RP et al. Genetic determination of acute phase reactant levels: the strong heart study. Hum Hered 2004;58:112-116.
14. de Maat MP, Bladbjerg EM, Hjelmborg JB et al. Genetic influence on inflammation variables in the elderly. Arterioscler Thromb Vasc Biol 2004;24:2168-2173.
15. Ding K, Feng D, de Andrade M et al. Genomic regions that influence plasma levels of inflammatory markers in hypertensive sibships. J Hum Hypertens 2008;22:102-110.
16. Tang W, Hong Y, Province MA et al. Familial clustering for features of the metabolic syndrome: the National Heart, Lung, and Blood Institute (NHLBI) Family Heart Study. Diabetes Care 2006;29:631-636.
17. Higgins M, Province M, Heiss G et al. NHLBI Family Heart Study: objectives and design. Am J Epidemiol 1996;143:1219-1228.
18. Williams RR, Rao DC, Ellison RC et al. NHLBI family blood pressure program: methodology and recruitment in the HyperGEN network. Hypertension genetic epidemiology network. Ann Epidemiol 2000;10:389-400.
19. Almasy L, Blangero J. Multipoint quantitative-trait linkage analysis in general pedigrees. Am J Hum Genet 1998;62:1198-1211.
20. Kruglyak L, Daly MJ, Reeve-Daly MP, Lander ES. Parametric and nonparametric linkage analysis: a unified multipoint approach. Am J Hum Genet 1996;58:1347-1363.
21. Amos C, de Andrade M, Zhu D. Comparison of multivariate tests for genetic linkage. Hum Hered 2001;51:133-144.
22. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Royal Stat Soc 1995;85:289-300.
23. Rankinen T, Zuberi A, Chagnon YC et al. The human obesity gene map: the 2005 update. Obesity 2006;14:529-644.
24. Dupuis J, Larson MG, Vasan RS et al. Genome scan of systemic biomarkers of vascular inflammation in the Framingham Heart Study: evidence for susceptibility loci on 1q. Atherosclerosis 2005;182:307-314.
25. Perusse L, Rice T, Chagnon Y et al. A genome-wide scan for abdominal fat assessed by computed tomography in the Quebec Family Study. Diabetes 2001;50:614-621.
26. Li W, Dong C, Li D, Zhao H, Price R. An obesity-related locus in chromosome region 12q23-24. Diabetes 2004;53:812-820.
27. Collaku A, Rankinen T, Rice T et al. A genome-wide linkage scan for dietary energy and nutrient intakes: the health, risk factors, exercise training, and genetics (HERITAGE) family study. Am J Clin Nutr 2004;79:881-886.
28. Palmer L, Buxbaum S, Larkin EK et al. Whole genome scan for obstructive sleep apnea and obesity in African-American families. Am J Respir Crit Care Med 2004;169:1314-1321.
29. Meyre D, Lecoeur C, Delplanque J et al. A genome-wide scan for childhood obesity-associated traits in French families shows significant linkage on chromosome 6q22.31-q23.2. Diabetes 2004;53:803-811.
30. Saar K, Geller F, Ruschendorf F et al. Genome scan for childhood and adolescent obesity in German families. Pediatrics 2003;111:321-327.
31. Minokoshi Y, Alquier T, Furukawa N et al. AMP-kinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamus. Nature 2004;428:569-574.
32. McCarty MF. AMPK activation may suppress hepatic production of C-reactive protein by stimulating nitric oxide synthase. Med Hypotheses 2004;63:328-333.
33. Steppan CM, Bailey ST, Bhat S et al. The hormone resistin links obesity to diabetes. Nature 2001;409:307-312.
34. McTernan PG, Fisher FM, Valsamakis G et al. Resistin and type 2 diabetes: regulation of resistin expression by insulin and rosiglitazone and the effects of recombinant resistin on lipid and glucose metabolism in human differentiated adipocytes. J Clin Endocrinol Metab 2003;88:6098-6106.
35. Shaw JT, Lovelock PK, Kesting JB et al. Novel susceptibility gene for late-onset NIDDM is localized to human chromosome 12q. Diabetes 1998;47:1793-1796.
36. Lindgren CM, Mahtani MM, Widén E et al. Genomewide search for type 2 diabetes mellitus susceptibility loci in Finnish families: the Botnia study. Am J Hum Genet 2002;70:509-516.
37. Rotimi CN, Chen G, Adeyemo AA et al. A genome-wide search for type 2 diabetes susceptibility genes in West Africans: the Africa America Diabetes Mellitus (AADM) Study. Diabetes 2004;53:838-841.
38. Sjöholm A, Nyström T. Endothelial inflammation in insulin resistance. Lancet 2005;365:610-612.
39. McLaughlin T, Abbasi F, Lamendola C et al. Differentiation between obesity and insulin resistance in the association with C-reactive protein. Circulation 2002;106:2908-2912.
40. Freeman DJ, Norrie J, Caslake MJ et al. C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study. Diabetes 2002;51: 1596-1600.
41. Dandona P, Aljada A, Chaudhuri A, Bandyopadhyay A. The potential influence of inflammation and insulin resistance on the pathogenesis and treatment of atherosclerosis-related complications in type 2 diabetes. J Clin Endocrinol Metab 2003;88:2422-2429.
42. Thorand B, Baumert J, Doring A et al. Sex differences in the relation of body composition to markers of inflammation. Atherosclerosis 2006;184: 216-224.
43. Seidell JC, Oosterlee A, Thijssen MA et al. Assessment of intra-abdominal and subcutaneous abdominal fat: relation between anthropometry and computed tomography. Am J Clin Nutr 1987;45:7-13.
44. Schreiner PJ, Terry JG, Evans GW et al. Sex-specific associations of magnetic resonance imaging-derived intra-abdominal and subcutaneous fat areas with conventional anthropometric indices-the atherosclerosis risk in communities. Am J Epidemiol 1996;144:335-345.